SDIC Jili
AI overview
Sign in and the AI will write an overview from our coverage.
Headlines · 1
- NeuroXess Raises RMB 700 Million for Implantable BCI Development
NeuroXess completed a RMB 700 million Series B financing led by SDIC Jili, Shenzhen Capital Group and Qinzhi Capital, according to 36Kr and IT之家. Proceeds will support multicenter registration trials and approval for its “three-all” implantable brain-computer interface system, a mass-production factory, next-generation products and BCI+AI research. NeuroXess says the fully implantable, fully wireless system has entered registration clinical trials, while its safety and performance advantages remain company-reported.
36氪 人工智能 · 🔥 0
Experience and discussion from the community
Share my SDIC Jili experienceAsk about SDIC Jili
Nobody has shared their experience with SDIC Jili yet.